Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01504334
What this trial is testing

Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Beijing Kawin Technology Share-Holding Co., Ltd. 80
Not applicableUnknownNCT04197791
What this trial is testing

Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Istanbul University - Cerrahpasa 36
Large-scale testing (Phase 3)Study completedNCT00071461
What this trial is testing

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Actelion 158
Not applicableEnrolling By InvitationNCT06629623
What this trial is testing

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chu Hongling 310
Not applicableStudy completedNCT02501668
What this trial is testing

The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease

Who this might be right for
Lung Diseases, InterstitialLung Cancer
Keimyung University Dongsan Medical Center 1,375,842
Large-scale testing (Phase 3)Study completedNCT00650091
What this trial is testing

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Who this might be right for
Pulmonary Fibrosis
Duke University 264
Early research (Phase 1)Study completedNCT05195918
What this trial is testing

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hal Chapman 50
Not applicableUnknownNCT06113991
What this trial is testing

Study Comparing Chronic Beryllium Disease to Pulmonary Sarcoidosis

Who this might be right for
Pulmonary SarcoidosisChronic Beryllium Disease
Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT04507893
What this trial is testing

Comparison Between Positive and Negative COVID-19 Pneumonia

Who this might be right for
Covid19Interstitial Pneumonia
University of Palermo 80
Not applicableActive Not RecruitingNCT07048652
What this trial is testing

Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases

Who this might be right for
Idiopathic Pulmonary Fibrosis
Superior University 68
Testing effectiveness (Phase 2)Study completedNCT03814317
What this trial is testing

Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Who this might be right for
SarcoidosisPrecapillary Pulmonary HypertensionInterstitial Lung Disease
University of Florida 5
Not applicableStudy completedNCT05022784
What this trial is testing

Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 1,798
Not applicableLooking for participantsNCT07457463
What this trial is testing

Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)

Who this might be right for
Lung Fibrosis Interstitial
Insel Gruppe AG, University Hospital Bern 80
Not applicableStudy completedNCT04205708
What this trial is testing

Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

Who this might be right for
SilicosisPneumoconiosis; Silica
University of Oklahoma 183
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Not applicableUnknownNCT05402176
What this trial is testing

The SHIELD Whole Lung Lavage Study

Who this might be right for
Silicosis
The University of Queensland 30
Testing effectiveness (Phase 2)Study completedNCT01766817
What this trial is testing

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb 325
Testing effectiveness (Phase 2)Study completedNCT03385668
What this trial is testing

Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies

Who this might be right for
Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 7
Testing effectiveness (Phase 2)WithdrawnNCT01524068
What this trial is testing

Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Pittsburgh
Next Page